Targeting the endocannabinoid system for the treatment of abdominal pain in irritable bowel syndrome

Nature Reviews Gastroenterology & Hepatology, Published online: 27 September 2022; doi:10.1038/s41575-022-00682-yThere are limited available treatment options for the management of abdominal pain in irritable bowel syndrome (IBS). This Review provides an overview of the gastrointestinal endocannabinoid system and its potential as a therapeutic target for the treatment of pain in IBS.

Source: Nature Reviews Gastroenterology and Hepatology - September 27, 2022 Category: Gastroenterology Authors: Stuart M. Brierley Beverley Greenwood-Van Meerveld Giovanni Sarnelli Keith A. Sharkey Martin Storr Jan Tack Source Type: research